Wednesday, June 10, 2026

pharma Β· Ulcerative colitis Β· central nervous system (CNS) lymphomas Β· RANI

Rani Therapeutics Holdings

Rani Therapeutics Holdings clinical programs β€” 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

San Jose, USA HQ
2012 Founded
99 Employees
Public company Type
RANI Β· NYSE Ticker
Company details
Status
Public
HQ
San Jose, USA
Founded
2012
Employees
99
Programs
7
Drugs
12
Patents
148
Intelligence Β· Clinical Programs

Rani Therapeutics Holdings projects

1 ClinicalTrials.gov programs sponsored by Rani Therapeutics Holdings.

Rani Therapeutics Holdings has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. Berubicin hydrochloride

    Rani Therapeutics Holdings

    central nervous system (CNS) lymphomas

    phase 2 small molecule active

    1 trial

Frequently asked questions

How many clinical projects does Rani Therapeutics Holdings have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.